Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
CA 2503536 A1 · Owner: Celgene Corporation · Inventors: Manning, Donald C.; Zeldis, Jerome B.; Faleck, Herbert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt solvate, hydrate, stereoisomer, clathrate or prodrug thereof, alone or in combination with a second active agent and/or surgery psychological or physical therapy. , Pharmaceutical compositions single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.